Researchers have created a new approach that focuses on treating the effects of mutations to a gene known as Syngap1. Animals models show that mutations in Syngap1 reduce the number of functional proteins are responsible for the causes of sporadic intellectual disability and are associated with schizophrenia and autism spectrum disorder.
“Our hope is that these studies will eventually lead to a therapy specifically designed for patients with psychiatric disorders caused by damaging Syngap1 mutations,” said Gavin Rumbaugh, associate professor at The Scripps Research Institute who led the study.
Sporadic intellectual disability affects approximately one percent of the worldwide population, suggesting that tens of thousands of individuals with intellectual disability may carry damaging Syngap1 mutations without knowing it.
http://www.science20.com/news_articles/personalized_treatment_for_intellectual_disability_developed-152544
“Our hope is that these studies will eventually lead to a therapy specifically designed for patients with psychiatric disorders caused by damaging Syngap1 mutations,” said Gavin Rumbaugh, associate professor at The Scripps Research Institute who led the study.
Sporadic intellectual disability affects approximately one percent of the worldwide population, suggesting that tens of thousands of individuals with intellectual disability may carry damaging Syngap1 mutations without knowing it.
http://www.science20.com/news_articles/personalized_treatment_for_intellectual_disability_developed-152544
RSS Feed
